XENCOR, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.66 USD | -2.39% |
|
-1.13% | +11.45% |
| Apr. 16 | BTIG Cuts Price Target on Xencor to $38 From $56, Keeps Buy Rating | MT |
| Apr. 09 | Xencor Names Bart Cornelissen as Chief Financial Officer | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XENCOR, INC. | Bio Therapeutic Drugs | -2.39% | -1.13% | +11.45% | -13.46% | -26.52% | 1.49B |  |  | |
- Stock Market
- Equities
- XNCR Stock
- Charts Xencor, Inc.
- Relative Strength Chart